home / stock / anix / anix news


ANIX News and Press, Anixa Biosciences Inc. From 06/01/20

Stock Information

Company Name: Anixa Biosciences Inc.
Stock Symbol: ANIX
Market: NASDAQ
Website: anixa.com

Menu

ANIX ANIX Quote ANIX Short ANIX News ANIX Articles ANIX Message Board
Get ANIX Alerts

News, Short Squeeze, Breakout and More Instantly...

ANIX - Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for Testing in Biological Assays

SAN JOSE, Calif. , June 1, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that the Company, together with partner OntoChem GmbH, has synthesized f...

ANIX - NCLH, FIVN among premarket losers

Hertz Global Holdings (NYSE: HTZ )  -16%  after it enters into forbearances and limited waivers . More news on: Hertz Global Holdings, Inc., Centennial Resource Development, Inc., Compass Diversified Holdings LLC, Stocks on the move, , Read more ...

ANIX - CGC, STWD among premarket gainers

Stemline Therapeutics (NASDAQ: STML ) +151%  on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...

ANIX - Anixa Bio up 62% premarket on discovery of first COVID-19 candidate

Anixa Biosciences (NASDAQ: ANIX ), together with partner OntoChem GmbH, has identified its first therapeutic candidate against COVID-19 and has advanced the compound into biological testing. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Stocks on the move, Read ...

ANIX - Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate

SAN JOSE, Calif. , May 4, 2020 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it, with partner OntoChem GmbH, has identified its first therap...

ANIX - Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights Highlighting Cchek(TM) Liquid Biopsy Technology

SAN JOSE, Calif. , April 23, 2020 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced the publication of a peer-reviewed journal article in Biomarker ...

ANIX - Anixa Bio up 30% premarket on plan to develop COVID-19 drugs

Thinly traded nano cap Anixa Biosciences (NASDAQ: ANIX ), a developer of cancer therapies, has agreed to collaborate with OntoChem GmbH to discover and develop antiviral candidates for the potential treatment of COVID-19. More news on: Anixa Biosciences, Inc., Healthcare stocks news, Sto...

ANIX - Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics

SAN JOSE, Calif. , April 20, 2020 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, today announced that it has entered into a strategic collaboration with OntoChem ...

ANIX - Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector Reformulation for CAR-T Program

SAN JOSE, Calif. , Feb. 12, 2020 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that the research team lead by Dr. Jose Conejo-Garcia , Chair of the Departm...

ANIX - 23andMe to cut 14% of staff as business slows

Home DNA testing services provider 23andMe ( DNA ) plans to terminate 100 people, 14% of its workforce, in response to weakening sales. Most of the cuts will affect operations teams that were focused on growth and scaling efforts. More news on: 23andMe, Anixa Biosciences, Inc., Guardant ...

Previous 10 Next 10